First-in-Human Study of FLX925 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT02335814 · TERMINATED
Trial details
- NCT number
- NCT02335814
- Sponsor
- RAPT Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-08
- Primary completion
- 2017-05-03
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.